SCHEMBL5454330

SCHEMBL5454330

CCCCC/C=C\C/C=C\CCCCCCCC(=O)Oc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCL9 O00512 1/20 0.65
▸ CTNNB1 P35222 1/20 0.65
▸ MGLL Q99685 2/20 0.56
▸ FABP3 P05413 3/20 0.51
▸ ALDH1A1 P00352 5/20 0.49
▸ F7 P08709 4/20 0.49
▸ F3 P13726 4/20 0.49
▸ KDM4E B2RXH2 3/20 0.49
▸ PPARG P37231 3/20 0.49
▸ PPARD Q03181 3/20 0.49
▸ PPARA Q07869 3/20 0.49
▸ FFAR1 O14842 3/20 0.49
▸ PTGS1 P23219 2/20 0.49
▸ DUSP3 P51452 1/20 0.49
▸ PTPN7 P35236 1/20 0.49
▸ LMNA P02545 1/20 0.49
▸ CYP3A4 P08684 1/20 0.49
▸ CYP19A1 P11511 1/20 0.49
▸ FABP4 P15090 1/20 0.49
▸ HPGD P15428 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13729888 0.99 BCL9 (0.67) BCL9CTNNB1MGLLFABP3ALDH1A1
SCHEMBL11761443 0.99 BCL9 (0.67) BCL9CTNNB1MGLLFABP3ALDH1A1
SCHEMBL11761431 0.99 BCL9 (0.67) BCL9CTNNB1MGLLFABP3ALDH1A1
SCHEMBL13164410 0.99 BCL9 (0.67) BCL9CTNNB1MGLLFABP3ALDH1A1
SCHEMBL1942721 0.99 BCL9 (0.67) BCL9CTNNB1MGLLFABP3ALDH1A1
SCHEMBL1942724 0.99 BCL9 (0.67) BCL9CTNNB1MGLLFABP3ALDH1A1
SCHEMBL9615216 0.93 BCL9 (0.57) BCL9CTNNB1MGLLFABP3ALDH1A1
SCHEMBL13184391 0.91 BCL9 (0.63) BCL9CTNNB1MGLLFABP3ALDH1A1
SCHEMBL22531036 0.91 BCL9 (0.78) BCL9CTNNB1MGLLALDH1A1PTPN7
SCHEMBL14401931 0.91 BCL9 (0.78) BCL9CTNNB1MGLLALDH1A1PTPN7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230250406-A1 MUTANT LIPASE AND USE THEREOF DSM IP ASSETS B.V. (NL) 2023-08-10 — — US disclosed
US-11667902-B2 Lipolytic enzyme variants DSM IP ASSETS B.V. (NL) 2023-06-06 — — US disclosed
US-20230080079-A1 MUTANT LIPASE AND USE THEREOF DSM IP ASSETS B.V. (NL) 2023-03-16 — — US disclosed
US-20210087542-A1 LIPOLYTIC ENZYME VARIANTS DSM IP ASSETS B.V. (NL) 2021-03-25 — — US disclosed
EP-3794115-A2 MUTANT LIPASE AND USE THEREOF DSM IP Assets B.V. (NL) 2021-03-24 — — EP disclosed
EP-3794114-A2 MUTANT LIPASE AND USE THEREOF DSM IP Assets B.V. (NL) 2021-03-24 — — EP disclosed
US-10918113-B2 Lipolytic enzyme variants DSM IP ASSETS B.V. (NL) 2021-02-16 — — US disclosed
US-10889807-B2 Lipolytic enzyme variants DSM IP ASSETS B.V. (NL) 2021-01-12 — — US disclosed
CN-112135903-A Mutant lipase and use thereof 帝斯曼知识产权资产管理有限公司 2020-12-25 — — CN disclosed
US-20190335764-A1 LIPOLYTIC ENZYME VARIANTS DSM IP ASSETS B.V. (NL) 2019-11-07 — — US disclosed
US-20190338261-A1 LIPOLYTIC ENZYME VARIANTS DSM IP ASSETS B.V. (NL) 2019-11-07 — — US disclosed
EP-3559221-A1 LIPOLYTIC ENZYME VARIANTS DSM IP Assets B.V. (NL) 2019-10-30 — — EP disclosed
EP-3559222-A1 LIPOLYTIC ENZYME VARIANTS DSM IP Assets B.V. (NL) 2019-10-30 — — EP disclosed
WO-2018114912-A1 LIPOLYTIC ENZYME VARIANTS DSM IP ASSETS B.V. (NL) 2018-06-28 — — WO disclosed
WO-2018114940-A1 LIPOLYTIC ENZYME VARIANTS DSM IP ASSETS B.V. (NL) 2018-06-28 — — WO disclosed
WO-2018114938-A1 LIPOLYTIC ENZYME VARIANTS DSM IP ASSETS B.V. (NL) 2018-06-28 — — WO disclosed
WO-2018114941-A1 LIPOLYTIC ENZYME VARIANTS DSM IP ASSETS B.V. (NL) 2018-06-28 — — WO disclosed
US-20070122862-A1 Screening for lipolytic enzymes or amidase activity NOVOZYMES A/S (DK) 2007-05-31 — — US disclosed
EP-1682671-A1 SCREENING FOR LIPOLYTIC ENZYME OR AMIDASE ACTIVITY Novozymes A/S (DK) 2006-07-26 — — EP disclosed
WO-2005040410-A1 SCREENING FOR LIPOLYTIC ENZYME OR AMIDASE ACTIVITY NOVOZYMES A/S (DK) 2005-05-06 — — WO disclosed
Send feedback